Pure Global
94237e4dd5b65cd63432f791eb207bcb

RaFIA beta-hCG FIA Test

CTK BIOTECH, INC·II·Ecuador ARCSA·Registered March 11, 2022
Device classification
Risk class
II
Product type
In Vitro Diagnostic
Brand name
CTK Biotech®
Commercial name
19-199- Reagents/Kits for IVD Assays, Immunoassay, Standard.
Registration information
Analysis ID
94237e4dd5b65cd63432f791eb207bcb
Registration date
March 11, 2022
Expiration date
March 11, 2027
Manufacturer
Name
CTK BIOTECH, INC
City
POWAY
Country
UNITED STATES
Address
13855 STOWE DRIVE
Product owner
Name
CTK BIOTECH, INC
Country
UNITED STATES
Authorized representative
Name
MEDIBAC-INC S.A.S.
Address
URDESA CENTRAL AV. VICTOR EMILIO ESTRADA 917 BETWEEN HIGUERAS AND ILANES
Phone
2881414
Product use

FOR IN VITRO DIAGNOSIS: THE FLUORESCENCE IMMUNOASSAY (FIA) HUMAN ORIONIC GONADOTROPIN (Β-HCG) GLYCOPROTEIN HORMONE TEST, IS A FLUORESCENCE CHROMATOGRAPHIC IMMUNOASSAY LATERAL FLOW TEST FOR THE QUANTITATIVE DETECTION OF Β-HCG IN HUMAN SERUM, PLASMA OR BLOOD,

About this record

Access comprehensive regulatory information for RaFIA beta-hCG FIA Test in the Ecuador medical device market through Pure Global AI's free database. This II medical device is registered under ARCSA ID 94237e4dd5b65cd63432f791eb207bcb and manufactured by CTK BIOTECH, INC. The device was registered on March 11, 2022.

This page provides complete registration details including product type (In Vitro Diagnostic), manufacturer information, authorized representative details, and regulatory compliance data from the official Ecuador ARCSA medical device database. Pure Global AI offers free access to Ecuador's complete medical device registry.